Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 69.66% is 18% above its 5-year average of 59.04%, around the middle of its 5-year range (32.37%–100.00%).
2.56% above its 12-month average of 67.92%.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): 68.10%.
GROSS MARGIN
69.66%
GROSS MARGIN AVG TTM
67.92%
GROSS MARGIN AVG 3Y
55.48%
GROSS MARGIN AVG 5Y
59.04%
GROSS MARGIN AVG 10Y
51.93%
GROSS MARGIN AVG 15Y
59.62%
GROSS MARGIN AVG 20Y
68.77%
CURRENT VS TTM AVG
+2.56%
CURRENT VS 3Y AVG
+25.55%
CURRENT VS 5Y AVG
+17.99%
CURRENT VS 10Y AVG
+34.15%
CURRENT VS 15Y AVG
+16.84%
CURRENT VS 20Y AVG
+1.29%
SECTOR MEDIAN · HEALTHCARE
41.20%
median of 862 covered companies
CURRENT VS SECTOR MEDIAN
+69.06%
vs the sector median at left
Caris Life Sciences, Inc.
Market Cap
$7.76B
Gross Margin
69.66%
TTM Avg
67.92%
3Y Avg
55.48%
5Y Avg
59.04%
Market Cap
$7.81B
Gross Margin
0.00%
TTM Avg
-840.99%
3Y Avg
-1281.95%
5Y Avg
-854.63%
Market Cap
$7.63B
Gross Margin
84.97%
TTM Avg
-824.36%
3Y Avg
-1521.85%
5Y Avg
-1048.03%
Market Cap
$7.99B
Gross Margin
82.36%
TTM Avg
85.98%
3Y Avg
89.10%
5Y Avg
90.76%
Market Cap
$7.31B
Gross Margin
98.16%
TTM Avg
98.36%
3Y Avg
98.29%
5Y Avg
98.36%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Caris Life Sciences, Inc. (CAI) | $7.76B | 69.66% | 67.92% | 55.48% | 59.04% |
| Praxis Precision Medicines, Inc. (PRAX)vs › | $7.81B | 0.00% | -840.99% | -1281.95% | -854.63% |
| Cytokinetics, Incorporated (CYTK)vs › | $7.63B | 84.97% | -824.36% | -1521.85% | -1048.03% |
| HealthEquity, Inc. (HQY)vs › | $7.61B | 75.21% | 63.63% | 56.54% | 52.91% |
| Hinge Health, Inc. (HNGE)vs › | $7.61B | 84.52% | 78.41% | 74.39% | 74.39% |
| TG Therapeutics, Inc. (TGTX)vs › | $7.99B | 82.36% | 85.98% | 89.10% | 90.76% |
| Ionis Pharmaceuticals, Inc. (IONS)vs › | $7.31B | 98.16% | 98.36% | 98.29% | 98.36% |
| Oscar Health, Inc. (OSCR)vs › | $8.38B | 14.38% | 17.24% | 38.82% | 59.22% |
| Alkermes plc (ALKS)vs › | $6.99B | 84.56% | 85.47% | 84.03% | 83.69% |
| Arrowhead Pharmaceuticals, Inc. (ARWR)vs › | $8.67B | 100.00% | -161.83% | -33.28% | -5.52% |
Gross Margin
69.7%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 68.10% |
| 2026-03-31 | 65.39% |
| 2025-12-31 | 75.43% |
| 2025-09-30 | 68.03% |
| 2025-06-30 | 62.67% |
| 2025-03-31 | 47.19% |
| 2024-12-31 | 54.42% |
| 2024-09-30 | 43.70% |
| 2024-06-30 | 37.54% |
| 2024-03-31 | 32.37% |
| 2021-09-30 | 53.64% |
| 2021-06-30 | 100.00% |
| 2021-03-31 | 47.76% |
| 2020-12-31 | 63.41% |
| 2020-09-30 | 61.51% |
| 2020-06-30 | 61.91% |
| 2020-03-31 | 48.71% |
| 2019-12-31 | 47.53% |
| 2019-09-30 | 48.14% |
| 2019-06-30 | 48.14% |
| 2019-03-31 | 49.33% |
| 2018-12-31 | 49.46% |
| 2018-09-30 | 49.06% |
| 2018-06-30 | 49.17% |
| 2018-03-31 | 50.18% |
| 2017-12-31 | 52.48% |
| 2017-09-30 | 49.38% |
| 2017-06-30 | 47.11% |
| 2017-03-31 | 44.74% |
| 2016-12-31 | 42.63% |
| 2016-09-30 | 38.94% |
| 2016-06-30 | 51.66% |
| 2016-03-31 | 55.24% |
| 2015-12-31 | 19.37% |
| 2015-09-30 | 58.45% |
| 2015-06-30 | 62.89% |
| 2015-03-31 | 63.72% |
| 2014-12-31 | 65.36% |
| 2014-09-30 | 66.41% |
| 2014-06-30 | 65.55% |
| 2014-03-31 | 65.61% |
| 2013-12-31 | 66.82% |
| 2013-09-30 | 67.74% |
| 2013-06-30 | 69.27% |
| 2013-03-31 | 69.91% |
| 2012-12-31 | 14.98% |
| 2012-09-30 | 95.11% |
| 2012-06-30 | 95.38% |
| 2012-03-31 | 94.71% |
| 2011-12-31 | 94.50% |
| 2011-09-30 | 96.77% |
| 2011-06-30 | 95.27% |
| 2011-03-31 | 96.05% |
| 2010-12-31 | 95.13% |
| 2010-09-30 | 95.09% |
| 2010-06-30 | 89.85% |
| 2010-03-31 | 85.58% |
| 2009-12-31 | 84.66% |
| 2009-09-30 | 85.80% |
| 2009-06-30 | 85.44% |
| 2009-03-31 | 90.27% |
| 2008-12-31 | 92.76% |
| 2008-09-30 | 95.55% |
| 2008-06-30 | 93.46% |
| 2008-03-31 | 94.94% |
| 2007-12-31 | 95.46% |
| 2007-09-30 | 94.42% |
| 2007-06-30 | 91.86% |
| 2007-03-31 | 92.65% |
| 2006-12-31 | 100.00% |
| 2006-09-30 | 100.00% |
| 2006-06-30 | 100.00% |
| 2006-03-31 | 100.00% |
